AT Impf
Europe, Bayern, Germany, Munich
Description
AT Impf was added in 2010.
Investor Profile
AT Impf has made 6 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series D (33%)
- Post Ipo Equity (17%)
- Series C (17%)
- Series E (17%)
- Series Unknown (17%)
Country Focus
- Germany (100%)
Industry Focus
- Biotechnology
- Medical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
